VMP 38750911000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Rizatriptan 10mg oral lyophilisates sugar free
BNF code 0407041R0AAACAC
Virtual Therapeutic Moiety Rizatriptan
Date identifier became valid 15 Jul 2020
Previous product identifier 322831007
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 10 May 2004
Previous name Rizatriptan 10mg oral lyophilisates
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Rizatriptan benzoate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 363573000
Strength value numerator 10.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route lyophilisate.oral
Dose Form
Formulation Oral lyophilisate
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Maxalt Melt 10mg oral lyophilisates (Lexon (UK) Ltd)
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd)
Maxalt Melt 10mg oral lyophilisates (Pilsco Ltd)
Maxalt Melt 10mg oral lyophilisates (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Rizatriptan 10mg oral lyophilisates sugar free 12 tablet
Rizatriptan 10mg oral lyophilisates sugar free 2 tablet
Rizatriptan 10mg oral lyophilisates sugar free 3 tablet
Rizatriptan 10mg oral lyophilisates sugar free 6 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback